 |
 |
|||||
 |
 |
 |
 |
 |
 |
|
Contact Information: Select Publications Levy DE , Meara ER. The effect of the 1998 Master Settlement Agreement on prenatal smoking. Journal of Health Economics, 2006; 25(2):276-294. Levy DE , O’Malley AJ, Normand ST. Estimating causal effects in the presence of treatment non-compliance, missing data, and continuous covariates. Statistics in Medicine 2004;23(15):2319-39. Vitale MG, Levy DE, Park MC, Choi H, Choe JC, Roye DP Jr. Quantifying risk of transfusion in children undergoing spine surgery. The Spine Journal 2002; 2(3):166-172. Vitale MG, Levy DE, Moskowitz AJ, Gelijns AC, Spellman M, Verdisco L, Roye DP. Capturing quality of life in pediatric orthopaedics: two recent measures compared. J Pediatric Orthopaedics 2001;21:629-635. Vitale MG, Levy DE, Johnson MG, Gelijns AC, Moskowitz AJ, Roye BD, Verdisco L, Roye DP. Assessment of quality of life in adolescent patients with orthopaedic problems: are adult measures appropriate? J Pediatric Orthopaedics 2001;21:622-628. Spratt TE, Schultz SS, Levy DE, Chen D, Schluter G, Williams GM. Different mechanisms for the photoinduced production of oxidative DNA damage by fluoroquinolones differing in photostability. Chem Res Toxicol 1999 Sep 20;12(9):809-815. |
Douglas E. Levy, PhD
Dr. Levy, a researcher with expertise in statistics and evaluative sciences, has focused on reducing the harm of tobacco use as a public health and policy priority. He is interested in investigating and influencing how public and private entities act to encourage healthy behaviors, and how those changes affect health and health care spending. Dr. Levy has also been involved in research exploring the ethical and economic issues surrounding the diffusion of genomic medicine, and the potential to channel the emerging understanding of genetic science into improved health and health care efficiency. He has merged his interests in genetics and tobacco, investigating physicians’ and patients’ attitudes towards genetically-tailored smoking cessation treatment. Dr. Levy was an Agency for Healthcare Research and Quality post-doctoral fellow in health services research at the Harvard School of Public health before joining the Mongan Institute for Health Policy in 2006.
